Empire Financial Management Company »

Y Mabs Therapeutics shares owned by Empire Financial Management Company

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Empire Financial Management Company from 13F filings

Historical chart of Empire Financial Management Company investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Empire Financial Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Empire Financial Management Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $210k 16k 13.15

More positions owned by Empire Financial Management Company

Etf Series Solutions Distillate Us (DSTL)
Microsoft Corporation (MSFT)
Apple (AAPL)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
International Business Machines (IBM)
Litman Gregory Funds Trust Imgp Dbi Managed (DBMF)
Amazon (AMZN)
Home Depot (HD)
Constellation Energy (CEG)
Lockheed Martin Corporation (LMT)
Abbott Laboratories (ABT)
Pacer Fds Tr Globl Cash Etf (GCOW)
Ea Ser Tr Marketdesk Focus (FDIV)
American Express Company (AXP)

View all positions for Empire Financial Management Company

Top funds holding Y Mabs Therapeutics

Paradigm Biocapital Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Cormorant Asset Management
Caligan Partners
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Pictet Asset Management Holding SA
Soleus Capital Management
Dimensional Fund Advisors
Northern Trust
Citadel Advisors

View all funds holding Y Mabs Therapeutics